CHH
Choice Hotels International, Inc.
CHH trails on the overall score without a compensating advantage in the available component scores.
LCID
Lucid Group, Inc.
LCID has the edge over CHH overall, supported by stronger modeled upside and stronger fundamentals.
CHH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
CHH's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CHH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $73.78 | -38% |
| Forward | 16x | $118 | — |
| Fair | 21x | $95.93 | -19% |
| Current | 26x | $118 | — |
| Expensive | 35x | $155 | +31% |
Historical ranges are pointers, not guarantees.
CHH's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CHH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CHH, but weaker profitability.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CHH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +68% |
| Q3 2026 | $4.48 | -45% |
| Q2 2026 | $7.06 | +9.1% |
| Q1 2026 | $7.40 | +13% |
| Q4 2025 | $7.90 | +27% |
| Q3 2025 | $8.11 | +55% |
| Q2 2025 | $6.47 | +34% |
| Q1 2025 | $6.52 | +40% |
| Q4 2024 | $6.20 | +22% |
CHH has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CHH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $458.3M | +2.5% |
| Q2 2026 | $440.8M | +3.4% |
| Q1 2026 | $340.6M | +2.3% |
| Q4 2025 | $390.2M | +0.1% |
| Q3 2025 | $447.3M | +4.5% |
| Q2 2025 | $426.4M | -2% |
| Q1 2025 | $332.9M | +0.3% |
| Q4 2024 | $389.8M | +8.8% |
CHH's revenue grew through 2023 and has held roughly level since: $458M last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -8.6 points |
| Q2 2026 | 24% | -5.6 points |
| Q1 2026 | 18% | -6.4 points |
| Q4 2025 | 26% | -4.6 points |
| Q3 2025 | 32% | -3.6 points |
| Q2 2025 | 29% | -1.3 points |
| Q1 2025 | 24% | +5.9 points |
| Q4 2024 | 31% | +20 points |
CHH has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CHH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CHH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | -9.7% |
| Q2 2026 | $80.1M | +22% |
| Q1 2026 | -$40M | -$25M |
| Q4 2025 | $64.1M | +12% |
| Q3 2025 | $49.1M | -70% |
| Q2 2025 | $65.4M | -8% |
| Q1 2025 | -$15M | +$16M |
| Q4 2024 | $57.4M | +296% |
CHH has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CHH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -317K shares |
| 1 year | -3% | -1.4M shares |
| 3 years | -11% | -5.4M shares |
| 5 years | -19% | -10.8M shares |
| Available history | -19% | -10.6M shares |
CHH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $58.7M |
| Q2 2026 | $51M |
| Q1 2026 | $56.5M |
| Q4 2025 | $25.3M |
| Q3 2025 | $202,000 |
| Q2 2025 | $48.1M |
| Q1 2025 | $64.6M |
| Q4 2024 | $31.8M |
CHH spent $192M buying back its own shares over the past year, up 32% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
CHH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.4x | Elevated |
CHH's net debt is about 4.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CHH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.3 | Neutral |
| Stochastic | 83.8 | Overbought |
CHH's weekly RSI is 62 (neutral) and its Stochastic is 84 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CHH PE vs Consumer Cyclical Sector
| Metric | CHH | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 47% above |
| PE % | 65 | 47 | 18 pts above |
CHH is trading at 26x earnings, a 47% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CHH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.4 | 8.1% above |
| 20 week MA | $107.8 | 9.8% above |
| 50 week MA | $106.2 | 11% above |
| 100 week MA | $115.5 | 2.5% above |
| 200 week MA | $119.2 | 0.8% below |
CHH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CHH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.9 | $104.1 | -0.8% |
| 2021 | $104.1 | $152.7 | +47% |
| 2022 | $152.7 | $112.2 | -27% |
| 2023 | $112.2 | $113.3 | +1% |
| 2024 | $113.3 | $140.8 | +24% |
| 2025 | $140.8 | $96.0 | -32% |
| 2026 YTD | $96.0 | $118.3 | +23% |
CHH has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.